List of works - Nicolás Merchante

Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C

scientific article published on 01 January 2006

Bacterial translocation and clinical progression of HCV-related cirrhosis in HIV-infected patients

scientific article published on 7 August 2017

Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life

scientific article published in Scientific Reports

Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis

scientific article published on 19 February 2013

Bilateral enophthalmos as a manifestation of HIV infection-related lipoatrophy

scientific article published on 01 November 2004

Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus-Infected Patients With Nonalcoholic Fatty Liver Disease.

scientific article published on September 2017

Changes in liver steatosis evaluated by transient elastography with the controlled attenuation parameter in HIV-infected patients

scientific article

Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin

scientific article published on 22 July 2010

Changes in the response to treatment against chronic hepatitis C between 1999 and 2015: data from a prospective cohort

scientific article

Coexistence of pyoderma gangrenosum and Sweet's syndrome in a patient with ulcerative colitis

scientific article published on 01 December 2007

Digoxin toxicity secondary to inhibition of digoxin intestinal metabolism in a patient receiving clarithromycin

scientific article published in November 2004

Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine

scientific article published in March 2004

Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatment

scientific article published on 6 October 2011

Executive summary: Consensus document of GEHEP of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), along with SOCIDROGALCOHOL, SEPD and SOMAPA on hepatitis C virus infection management in drug users

article

Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)

article

Fat mass and obesity-associated gene variations are related to fatty liver disease in HIV-infected patients.

scientific article published on 24 January 2017

Genetic markers of lipid metabolism genes associated with low susceptibility to HCV infection

scientific article published on 21 June 2019

HAART and the liver: friend or foe?

scientific article published on March 2010

HIV-coinfection leads to a modest increase in plasma HCV-RNA load in patients with chronic HCV infection

scientific article published on 29 June 2012

HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma.

scientific article published on January 2014

Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients.

scientific article published on 11 September 2012

Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C.

scientific article published on 23 July 2015

Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients

article

High frequency of potential interactions between direct-acting antivirals and concomitant therapy in HIV/hepatitis C virus-coinfected patients in clinical practice.

scientific article

High prevalence of antibodies against hepatitis E virus in HIV-infected patients with unexplained liver disease

scientific article published on December 2014

High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack

scientific article published in July 2008

Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin

scientific article published on 9 July 2015

Impact of genetic polymorphisms associated with nonalcoholic fatty liver disease on HIV-infected individuals

scientific article published on September 2015

Incidence and natural history of hepatitis E virus coinfection among HIV-infected patients

scientific article published on August 2014

Incidence of and risk factors for insulin resistance in treatment-naive HIV-infected patients 48 weeks after starting highly active antiretroviral therapy

scientific article published on 01 January 2006

Incidence of liver damage of uncertain origin in HIV patients not co-infected with HCV/HBV.

scientific article

Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfection

scientific article

Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain

scientific article published on 05 September 2012

Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients

article

Insulin resistance is not a relevant predictor of sustained virological response to pegylated interferon plus ribavirin in HIV/HCV co-infected patients

scientific article published on 29 December 2008

Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients

scientific article published in July 2006

Latest pharmacotherapy options for treating hepatitis C in HIV-infected patients.

scientific article published on August 2014

Liver stiffness correlates with Child-Pugh-Turcotte and MELD scores in HIV/hepatitis C virus-coinfected patients with cirrhosis.

scientific article published on 9 March 2012

Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis

scientific article published on 6 June 2012

Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis

scientific article

Liver toxicity of antiretroviral combinations including fosamprenavir plus ritonavir 1400/100 mg once daily in HIV/hepatitis C virus-coinfected patients.

scientific article published on 20 June 2011

Low incidence of acute hepatitis C virus infection among Southern Spanish HIV-infected individuals

scientific article published on 3 February 2017

Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients

article

Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term.

scientific article published on 20 March 2015

Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients

scientific article published on 09 November 2006

Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.

scientific article published in October 2009

Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosine.

scientific article published on January 2010

Prevalence of non-significant liver fibrosis and rate of fibrosis progression in HIV/hepatitis C virus- co-infected patients: still a role for liver biopsy?

scientific article published in August 2004

Prevalence of serum antibodies against Bartonella ssp. in a health population from the south area of the Seville province

scientific article

Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis.

scientific article published on 7 December 2015

Real-life experience with sorafenib for the treatment of hepatocellular carcinoma in HIV-infected patients.

scientific article

Reassessment of genotype 1 hepatitis C virus subtype misclassification by LiPA 2.0: implications for direct-acting antiviral treatment

scientific article

Screening for Hepatocellular Carcinoma in HIV-Infected Patients: Current Evidence and Controversies

scientific article published on 01 February 2020

Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection

scientific article published on 27 September 2018

Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease

scientific article published on 01 January 2006

The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients.

scientific article

Transient Budd-Chiari syndrome due to iatrogenic subcapsular fluid accumulation following thoracocentesis

scientific article published on 01 November 2004

Twelve week post-treatment follow-up predicts sustained virological response to pegylated interferon and ribavirin therapy in HIV/hepatitis C virus co-infected patients.

scientific article published on 17 March 2011

[Non alcoholic steatosis in HIV infection]

scientific article published on 09 June 2009

List of works by Nicolás Merchante

Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C

Bacterial translocation and clinical progression of HCV-related cirrhosis in HIV-infected patients

Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life

Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis

Bilateral enophthalmos as a manifestation of HIV infection-related lipoatrophy

Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus-Infected Patients With Nonalcoholic Fatty Liver Disease.

Changes in liver steatosis evaluated by transient elastography with the controlled attenuation parameter in HIV-infected patients

Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin

Changes in the response to treatment against chronic hepatitis C between 1999 and 2015: data from a prospective cohort

Coexistence of pyoderma gangrenosum and Sweet's syndrome in a patient with ulcerative colitis

Digoxin toxicity secondary to inhibition of digoxin intestinal metabolism in a patient receiving clarithromycin

Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine

Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatment

Executive summary: Consensus document of GEHEP of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), along with SOCIDROGALCOHOL, SEPD and SOMAPA on hepatitis C virus infection management in drug users

Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)

Fat mass and obesity-associated gene variations are related to fatty liver disease in HIV-infected patients.

Genetic markers of lipid metabolism genes associated with low susceptibility to HCV infection

HAART and the liver: friend or foe?

HIV-coinfection leads to a modest increase in plasma HCV-RNA load in patients with chronic HCV infection

HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma.

Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients.

Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C.

Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients

High frequency of potential interactions between direct-acting antivirals and concomitant therapy in HIV/hepatitis C virus-coinfected patients in clinical practice.

High prevalence of antibodies against hepatitis E virus in HIV-infected patients with unexplained liver disease

High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack

Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin

Impact of genetic polymorphisms associated with nonalcoholic fatty liver disease on HIV-infected individuals

Incidence and natural history of hepatitis E virus coinfection among HIV-infected patients

Incidence of and risk factors for insulin resistance in treatment-naive HIV-infected patients 48 weeks after starting highly active antiretroviral therapy

Incidence of liver damage of uncertain origin in HIV patients not co-infected with HCV/HBV.

Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfection

Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain

Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients

Insulin resistance is not a relevant predictor of sustained virological response to pegylated interferon plus ribavirin in HIV/HCV co-infected patients

Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients

Latest pharmacotherapy options for treating hepatitis C in HIV-infected patients.

Liver stiffness correlates with Child-Pugh-Turcotte and MELD scores in HIV/hepatitis C virus-coinfected patients with cirrhosis.

Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis

Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis

Liver toxicity of antiretroviral combinations including fosamprenavir plus ritonavir 1400/100 mg once daily in HIV/hepatitis C virus-coinfected patients.

Low incidence of acute hepatitis C virus infection among Southern Spanish HIV-infected individuals

Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients

Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term.

Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients

Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.

Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosine.

Prevalence of non-significant liver fibrosis and rate of fibrosis progression in HIV/hepatitis C virus- co-infected patients: still a role for liver biopsy?

Prevalence of serum antibodies against Bartonella ssp. in a health population from the south area of the Seville province

Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis.

Real-life experience with sorafenib for the treatment of hepatocellular carcinoma in HIV-infected patients.

Reassessment of genotype 1 hepatitis C virus subtype misclassification by LiPA 2.0: implications for direct-acting antiviral treatment

Screening for Hepatocellular Carcinoma in HIV-Infected Patients: Current Evidence and Controversies

Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection

Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease

The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients.

Transient Budd-Chiari syndrome due to iatrogenic subcapsular fluid accumulation following thoracocentesis

Twelve week post-treatment follow-up predicts sustained virological response to pegylated interferon and ribavirin therapy in HIV/hepatitis C virus co-infected patients.

[Non alcoholic steatosis in HIV infection]